Strategic Investment Recent $100K investment from Accelerating Angels signals external validation and a potential channel for partnership or co-marketing to accelerate commercial expansion and evidence generation for ReFlow technology.

Global Partnerships Partnership with Neuro Kids to bring ReFlow technology to Africa (Zambia, Kenya, Uganda) highlights international market access needs, distribution opportunities, and potential for region-specific support products and training.

Regulatory Validation FDA Breakthrough Device Designation for ReFlow EVD underscores clinical impact and faster adoption potential, suggesting priority outreach to hospitals and neurocritical care centers seeking innovative CSF management solutions.

Expansion Readiness Commercial expansion initiatives and evidence generation efforts indicate readiness to engage major distributors and hospital systems; target accounts include neurocritical care units, PACU/ICU departments, and pediatric care facilities.

Leadership & Expertise Board appointment of a biomedical leadership and ongoing product launches (ReFlow Mini Flusher) point to a roadmap of new devices and upgrades, enabling upsell opportunities for existing customers and adjacent care settings.